The BROD GROUP Publications
To request a reprint of one of our manuscripts (list below),
please fill out our publication request form:
MAJOR PUBLICATIONS
Brod M, Bushnell DM, Busk AK, Neergaard JS.
Development and Validation of the Child Hemophilia Treatment Experience Measure: A New Observer-Reported Outcome Measure.
Haemophilia. 2024;1-15. https://doi.org/10.1111/hae.15102.
Brod M, Pfeiffer KM, Beck JF, Smith AJ.
Measuring Treatment Impacts on Symptoms in Adults with Hypoparathyroidism: Findings From the PaTHway Trial.
J Patient Rep Outcomes. 2024 Aug 13;8(1):94. doi: 10.1186/s41687-024-00757-1.
Brod M, Bushnell DM, Neergaard JS, Waldman LT, Busk AK.
Understanding Treatment Burden in Hemophilia: Development and Validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).
J Patient Rep Outcomes. 2023 Feb 23;7(1):17. doi: 10.1186/s41687-023-00550-6.
Sävendahl L, Battelino T, Rasmussen MH, Brod M, Röhrich S, Saenger P, Horikawa R.
Weekly Somapacitan in GH Deficiency: 4-Year Efficacy, Safety and Treatment/Disease Burden Results from REAL 3.
J Clin Endocrinol Metab. 2023 Mar 30:dgad183. doi: 10.1210/clinem/dgad183.
Brod M, Waldman LT, Sparre T, Busk AK.
Development and Validation of the Diabetes Pen Experience Measure: A New Patient-Reported Outcome Measure.
J Diabetes Sci Technol. 2023 May;17(3):705-714. doi: 10.1177/19322968221079396.
Brod M, Waldman LT, Shu AD, Smith A.
Content Validation of the SF-36v2® Health Survey Acute for Use in Hypoparathyroidism.
Qual Life Res. 2023 Jun;32(6):1795-1806. doi: 10.1007/s11136-023-03352-x.
Brod M, Rasmussen MH, Alolga S, Beck JF, Bushnell DM, Lee KW, Maniatis A.
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB).
Pharmacoecon Open. 2023 Jan;7(1):121-138. doi: 10.1007/s41669-022-00373-z.
Fifer SK, Choundry NK, Brod M, Hsu E, Milstein A.
Improving Adherence to Guidelines for Spine Pain Care: What Tools Could Support Primary Care Clinicians in Conforming to Guidelines?
BMJ Open Qual. 2022 Aug;11(3):e001868. doi: 10.1136/bmjoq-2022-001868.
Sävendahl L, Battelino T, Højby Rasmussen M, Brod M, Saenger P, Horikawa R.
Effective GH Replacement With Once-Weekly Somapacitan vs Daily GH in Children With GHD: 3-year Results from REAL 3.
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1357-1367. doi: 10.1210/clinem/dgab928.
Brod M, Waldman LT, Sparre T, Busk AK.
Development and Validation of the Diabetes Pen Experience Measure (DPEM): A New Patient-Reported Outcome Measure.
J Diabetes Sci Technol. 2022 Mar 14:19322968221079396. doi: 10.1177/19322968221079396.
Pfeiffer KM, Brod M, Smith A, Viuff D, Ota S, Charlton RW.
Functioning and Well-Being in Older Children and Adolescents With Achondroplasia: A Qualitative Study.
Am J Med Genet A. 2022 Feb;188(2):454-462. doi: 10.1002/ajmg.a.62534.
Khan AA, Rejnmark L, Rubin M, Schwarz P, Vokes T, Clarke B, Ahmed I, Hofbauer L, Marcocci C, Pagotto U, Palermo A, Eriksen E, Brod M, Markova D, Smith A, Pihl S, Mourya S, Karpf DB, Shu AD.
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e372-e385. doi: 10.1210/clinem/dgab577.
Pfeiffer KM, Brod M, Smith A, Viuff D, Ota S, Charlton RW.
A Qualitative Study of the Impacts of Having an Infant or Young Child With Achondroplasia on Parent Well-Being.
Orphanet J Rare Dis. 2021 Aug 6;16(1):351. doi: 10.1186/s13023-021-01978-z.
Brod M, McLeod L, Markova D, Gianettoni J, Mourya S, Lin Z, Shu A, Smith A.
Psychometric Validation of the Hypoparathyroidism Patient Experience Scales (HPES).
J Patient Rep Outcomes. 2021 Aug 10;5(1):70. doi: 10.1186/s41687-021-00320-2.
Brod M, Højby Rasmussen M, Vad K, Alolga S, Bushnell DM, Bedoin J, Maniatis A.
Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM).
Pharmacoecon Open. 2021 Jan 12. doi: 10.1007/s41669-020-00252-5.
Pfeiffer KM, Brod M, Smith A, Gianettoni J, Viuff D, Ota S, Charlton RW.
Assessing Physical Symptoms, Daily Functioning, and Well-being in Children with Achondroplasia.
Am J Med Genet A. 2021. Jan;185(1):33-45. doi: 10.1002/ajmg.a.61903.
Pfeiffer KM, Brod M, Smith A, Gianettoni J, Viuff D, Ota S, Charlton RW.
Assessing the Impacts of Having a Child With Achondroplasia on Parent Well-Being.
Qual Life Res. 2021 Jan;30(1):203-215. doi: 10.1007/s11136-020-02594-3.
Brod M, Waldman LT, Smith A, Karpf D.
Living with Hypoparathyroidism: Development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact).
Qual Life Res. 2021 Jan;30(1):277-291. doi: 10.1007/s11136-020-02607-1.
Waldman LT, Parthasarathy S, Villa KF, Bron M, Bujanover S, Brod M.
Understanding the Burden of Illness of Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea: A Qualitative Study.
Health Qual Life Outcomes. 2020 May 7;18(1):128. doi: 10.1186/s12955-020-01382-4.
Sävendahl L, Battelino T, Brod M, Rasmussen MH, Horikawa R, Juul RV, Saenger P.
Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1847-e1861. doi: 10.1210/clinem/dgz310.
Brod M, Waldman LT, Smith A, Karpf D.
Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).
Patient. 2020 Apr;13(2):151-162. doi: 10.1007/s40271-019-00388-5.
Tomaszewski KJ, Allen A, Mocarski M, Schiffman A, Kruger D, Handelsman Y, Heile M,
Brod M.
Divergence in Perceptions of Diabetes Control Among Patients With type 2 Diabetes Mellitus Treated With Basal Insulin and Health Care Professionals: Results From the US Perceptions of Control (POC-US) Study.
Patient Prefer Adherence. 2019 May 10;13:761-773. doi: 10.2147/PPA.S194598.
Brod M, Basse A, Markert M, Pfeiffer KM.
Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom.
Diabetes Ther. 2019 Aug;10(4):1323-1336. doi: 10.1007/s13300-019-0636-0.
Warren ML, Brod M, Håkan-Bloch J, Sparre T, Chaykin LB.
Patient-Reported Outcomes From a Randomized, Crossover Trial Comparing a Pen Injector With Insulin Degludec Versus a Pen Injector With Insulin Glargine U100 in Patients With Type 2 Diabetes.
Curr Med Res Opin. 2019 Sep;35(9):1623-1629. doi: 10.1080/03007995.2019.1605769.
Brod M, Beck JF, Højbjerre L, Bushnell DM, Adalsteinsson JE, Wilkinson L, Rasmussen MH.
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD).
Pharmacoecon Open. 2019 Mar;3(1):71-80. doi: 10.1007/s41669-018-0082-3.
Pfeiffer KM, Sandberg A, Nikolajsen A, Brod M.
Postprandial Glucose and Healthcare Resource Use: A Cross-Sectional Survey of Adults With Diabetes Treated With Basal-Bolus Insulin.
J Med Econ. 2018 Jan;21(1):66-73. doi: 10.1080/13696998.2017.1377208.
Brod M, Højbjerre L, Alolga SL, Beck JF, Wilkinson L, Rasmussen MH.
Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency.
Patient. 2017 Oct;10(5):653-666. doi: 10.1007/s40271-017-0237-9.
Brod M, Alolga SL, Beck JF, Wilkinson L, Højbjerre L, Rasmussen MH.
Understanding Burden of Illness for Child Growth Hormone Deficiency.
Qual Life Res 2017 Jul;26:1673–1686. doi: 10.1007/s11136-017-1529-1.
Ohashi Y, Wolden ML, Hyllested-Winge J, Brod M.
Diabetes Management and Daily Functioning Burden of Non-Severe Hypoglycemia in Japanese People Treated With Insulin.
J Diabetes Investig. 2017 Nov;8(6):776-782. doi: 10.1111/jdi.12642.
Tamborlane WV, Pfeiffer KM, Brod M, Nikolajsen A, Sandberg A, Peters AL, Van Name M.
Understanding Bolus Insulin Dose Timing: The Characteristics and Experiences of People With Diabetes Who Take Bolus Insulin.
Curr Med Res Opin. 2017 Apr;33(4):639-645. doi: 10.1080/03007995.2016.1275937.
Fifer S, Brod M, Milstein A.
Findings from the Pilot Study of Primary Care Referrals to Egoscue Method Clinic.
http://med.stanford.edu/cerc/research/care-models/spine-pain.html. Clinical Excellence Research Center (CERC). School of Medicine, Stanford University. Published May 2017.
Gelhorn HL, Dashiell-Aje E, Miller MG, DeRogatis LR, Dobs A, Seftel AD, Althof SE, Brod M, Revicki DA.
Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire.
J Sex Med. 2016 Nov;13(11):1737-1749. doi: 10.1016/j.jsxm.2016.09.006.
Brod M, Pfeiffer KM, Barnett AH, Berntorp K, Vilsbøll T, Weissenberger B.
Perceptions of Diabetes Control Among People With Type 2 Diabetes Treated With Basal Insulin in Sweden, Switzerland, and the United Kingdom.
Curr Med Res Opin. 2016 Oct;32(10):1653-1661. doi: 10.1080/03007995.2016.1198311.
Brod M, Nikolajsen A, Weatherall J, Pfeiffer KM.
Understanding Post-Prandial Hyperglycemia in Patients With Type 1 and Type 2 diabetes: A Web-Based Survey in Germany, the UK, and USA.
Diabetes Ther. 2016 Jun;7(2):335-48. doi: 10.1007/s13300-016-0175-x.
Brod M, Galstyan G, Unnikrishnan AG, Harman-Boehm I, Prusty V, Lavalle F, McGill M, Murphy A, Puchulu F.
Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results From the Second Wave of an International Cross-Sectional Survey.
Diabetes Ther. 2016 Jun;7(2):279-93. doi: 10.1007/s13300-016-0164-0.
Brod M, Nikolajsen A, Weatherall J, Pfeiffer KM.
The Economic Burden of Post-Prandial Hyperglycemia (PPH) Among People With Type 1 and Type 2 Diabetes in Three Countries.
Diabetes Ther. 2016 Mar;7(1):75-90. doi: 10.1007/s13300-016-0154-2.
Brod M, Pfeiffer KM, Barnett AH, Berntorp K, Vilsbøll T, Weissenberger B.
Perceptions of Diabetes Control Among Physicians and People With Type 2 Diabetes Uncontrolled on Basal Insulin in Sweden, Switzerland, and the United Kingdom.
Curr Med Res Opin. 2016 Jun;32(6):981-989. doi: 10.1185/03007995.2016.1150821.
Gelhorn HL, Vernon MK, Stewart KD, Miller MG, Brod M, Althof SE, DeRogatis LR, Dobs A, Seftel AD, Revicki DA.
Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.
Patient. 2016 Apr;9(2):181-190. doi: 10.1007/s40271-015-0138-8.
Brod M, Højbjerre L, Bushnell DM, Hansen CT.
Assessing the Impact of Non-Severe Hypoglycemic Events and Treatment in Adults: Development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).
Qual Life Res. 2015 Dec;24(12):2971-2984. doi:10.1007/s11136-015-1023-6.
Brod M, Blum SI, Bushnell DM, Ramasamy A.
Development and Validation of the Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure, a Patient-Reported Outcome Measure.
Qual Life Res. 2015 Dec;24(12):3001-3014. doi:10.1007/s11136-015-1037-0.
Tanaka Y, Brod M, Lane JR, Upadhyaya H.
What is a Clinically Relevant Improvement in Quality of Life in Adults with ADHD?
J Atten Disord. 2019 Jan;23(1):65-75. doi: 10.1177/1087054715580395. Epub 2015 Apr 15.
Brod M, Adler LA, Lipsius S, Tanaka Y, Heinloth AN, Upadhyaya H.
Validation of the Adult Attention-Deficit/Hyperactivity Disorder Quality-of-Life Scale in European Patients: Comparison With Patients From the USA.
Atten Defic Hyperact Disord. 2015 Jun;7(2):141-150. doi:10.1007/s12402-014-0160-z.
Brod M, Pohlman B, Hojbjerre L, Adalsteinsson JE, Rasmussen MH.
Impact of Adult Growth Hormone Deficiency on Daily Functioning and Well-Being.
BMC Res Notes. 2014 Nov 18;7; 813. doi: 10.1186/1756-0500-7-813.
Brod M, Pohlman B, Blum SI, Ramasamy A, Carson R.
Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study.
Patient. 2015 Aug;8(4):339-348. doi: 10.1007/s40271-014-0093-9.
Brod M, Alolga SL, Meneghini L.
Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities.
Patient. 2014 7(4):437-450. doi: 10.1007/s40271-014-0068-x.
Ampudia-Blasco FJ, Galan M, Brod M.
A Cross-Sectional Survey Among Patients and Prescribers on Insulin Dosing Irregularities and Impact of Mild (Self-Treated) Hypoglycemia Episodes in Spanish Patients With Type 2 Diabetes as Compared to Other European Patients.
Endocrinol Nutr. 2014 Oct;61(8):426-433. doi: 10.1016/j.endonu.2014.03.008.
Fulcher G, Singer J, Castaneda R, Fraige Filho F, Maffei L, Snyman J, Brod M.
The Psychosocial and Financial Impact of Non-Severe Hypoglycemic Events on People With Diabetes: Two International Surveys.
J Med Econ. 2014 Oct;17(10):751-761. doi: 10.3111/13696998.2014.946992.
Brod M, Wolden M, Groleau D, Bushnell DM.
Understanding the Economic, Daily Functioning, and Diabetes Management Burden of Non-Severe Nocturnal Hypoglycemic Events in Canada: Differences Between Type 1 and Type 2.
J Med Econ. 2014 Jan;17(1);11-20. doi: 10.3111/13696998.2013.857676.
Brod M, Pohlman B, Kongso JH.
Insulin Administration and the Impacts of Forgetting a Dose.
Patient. 2014 7(1):63-71. doi: 10.1007/s40271-013-0029-9.
Brod M, Hojbjerre L, Adalsteinsson JE, Rasmussen MH.
Assessing the Impact of Growth Hormone Deficiency and Treatment in Adults: Development of a New Disease-Specific Measure.
J Clin Endocrinol Metab. 2014 Apr;99(4):1204-1212. doi: 10.1210/jc.2013-3438.
Brod M, Wolden M, Christensen T, Bushnell DM.
Understanding the Economic Burden of Non-Severe Nocturnal Hypoglycemic Events: Impact on Work Productivity, Disease Management, and Resource Utilization.
Value Health. 2013 Dec;16(8):1140-1149. doi: 10.1016/j.jval.2013.09.002.
Brod M, Fennema H.
Validation of the Controlled Ovarian Stimulation Impact measure (COSI): Assessing the Patient Perspective.
Health Qual Life Outcomes. 2013 Jul 31;11:130. doi: 10.1186/1477-7525-11-130.
Philis-Tsimikas A, Brod M, Niemeyer M, Ocampo Francisco AM, Rothman J.
Insulin Degludec Once-Daily in Type 2 Diabetes: Simple or Step-Wise Titration (BEGIN: Once Simple Use).
Adv Ther. 2013 Jun;30(6):607-622. doi: 10.1007/s12325-013-0036-1.
Brod M, Pohlman B, Waldman LT.
Qualitative research and content validity.
In: Michalos AC, ed. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer; 2014. https://doi.org/10.1007/978-94-007-0753-5_3848.
Brod M, Wolden M, Christensen T, Bushnell DM.
A Nine Country Study of the Burden of Non-Severe Nocturnal Hypoglycemic Events on Diabetes Management and Daily Function
Diabetes Obes Metab. 2013 Jun;15(6):546-557. doi: 10.1111/dom.12070. Epub 2013 Feb 25.
Brod M, Rana A, Barnett AH.
Impact of Self-Treated Hypoglycaemia in Type 2 Diabetes: A Multinational Survey in Patients and Physicians.
Curr Med Res Opin. 2012 Dec;28(12):1947-1958. doi: 10.1185/03007995.2012.743457.
Brod M, Rana A, Barnett AH.
Adherence Patterns in Patients With Type 2 Diabetes on Basal Insulin Analogues: Missed, Mistimed and Reduced Doses.
Curr Med Res Opin. 2012 Dec;28(12):1933-1946. doi: 10.1185/03007995.2012.743458.
Brod M, Pohlman B, Wolden M, Christensen T.
Non-Severe Nocturnal Hypoglycemic Events: Experience and Impacts on Patient Functioning and Well-Being.
Qual Life Res. 2013 Jun;22(5):997-1004. doi: 10.1007/s11136-012-0234-3.
Brod M, Pohlman B, Lasser R, Hodgkins P.
Comparison of the Burden of Illness for Adults With ADHD Across Seven Countries: A Qualitative Study.
Health Qual Life Outcomes. 2012 May 14;10:47. doi: 10.1186/1477-7525-10-47.
Brod M, Christensen T, Bushnell DM.
The Impact of Non-Severe Hypoglycemic Events on Daytime Function and Diabetes Management Among Adults With Type 1 and Type 2 Diabetes.
J Med Econ. 2012;15(5):869-877. doi: 10.3111/13696998.2012.686465.
Brod M, Schmitt E, Goodwin M, Hodgkins P, Niebler G.
ADHD Burden of Illness in Older Adults: A Life Course Perspective.
Qual Life Res. 2012 Jun;21(5):795-799. doi: 10.1007/s11136-011-9981-9.
Brod M, Christensen T, Bushnell DM.
Impact of Nocturnal Hypoglycemic Events on Diabetes Management, Sleep Quality, and Next-Day Function: Results From a Four-Country Survey.
J Med Econ. 2012;15(1):77-86. doi: 10.3111/13696998.2011.624144.
Magasi S, Ryan G, Revicki D, Lenderking W, Hays RD, Brod M, Snyder C, Boers M, Cella D.
Content Validity of Patient-Reported Outcome Measures: Perspectives From a PROMIS Meeting.
Qual Life Res. 2012 Jun;21(5):739-746. doi: 10.1007/s11136-011-9990-8.
Brod M, Christensen T, Hammer M, Busk AK, Bushnell DM.
Examining the Ability to Detect Change Using the TRIM-Diabetes and TRIM-Diabetes Device Measures.
Qual Life Res. 2011 Nov;20(9):1513-1518. doi: 10.1007/s11136-011-9886-7.
Lucas-Carrasco R, Gomez-Benito J, Rejas J, Brod M.
The Spanish Version of the Dementia Quality of Life Questionnaire: A Validation Study.
Aging Ment Health. 2011 May;15(4):482-489. doi: 10.1080/13607863.2010.543658.
Brod M, Christensen T, Thomsen TL, Bushnell DM.
The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management.
Value Health. 2011 Jul-Aug;14(5):665-671. doi: 10.1016/j.jval.2011.02.001.
Brod M, Valensi P, Shaban JA, Bushnell DM, Christensen TL.
Patient Treatment Satisfaction After Switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ Study: An Analysis of the Influence of Prior and Current Treatment Factors.
Qual Life Res. 2010 Nov;19(9):1285-1293.
Brod M, Hammer M, Kragh N, Lessard S, Bushnell DM.
Development and Validation of the Treatment Related Impact Measure of Weight (TRIM-Weight).
Health Qual Life Outcomes. 2010 Feb 5;8:19. doi: 10.1186/1477-7525-8-19.
Brod M, Christensen T, Kongsø JH, Bushnell DM.
Examining and Interpreting Responsiveness of the Diabetes Medication Satisfaction Measure.
J Med Econ. 2009;12(4):309-316. doi: 10.3111/13696990903337017.
Brod M, Tesler LE, Christensen TL.
Qualitative Research and Content Validity: Developing Best Practices Based on Science and Experience.
Qual Life Res. 2009 Nov;18(9):1263-1278. doi: 10.1007/s11136-009-9540-9.
Brod M, Hammer M, Christensen T, Lessard S, Bushnell DM.
Understanding and Assessing the Impact of Treatment in Diabetes: The Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).
Health Qual Life Outcomes. 2009 Sep 9;7:83. doi: 10.1186/1477-7525-7-83.
Brod M, Kongsø JH, Lessard S, Christensen TL.
Psychological Insulin Resistance: Patient Beliefs and Implications for Diabetes Management.
Qual Life Res. 2009 Feb;18(1):23-32. doi: 10.1007/s11136-008-9419-1.
Brod M, Verhaak CM, Wiebinga CJ, Gerris J, Hoomans EHM.
Improving Clinical Understanding of the Effect of Ovarian Stimulation on Women’s Lives.
Reprod Biomed Online. 2009 Mar;18(3):391–400. doi: 10.1016/s1472-6483(10)60098-3.
Brod M, Rousculp M, Cameron A.
Understanding Compliance Issues for Daily Self-Injectable Treatment in Ambulatory Care Settings.
Patient Prefer Adherence. 2008 Feb 2;2:129-136.
Brod M, Christensen T, Bushnell D.
Maximizing the Value of Validation Findings to Better Understand Treatment Satisfaction Issues for Diabetes.
Qual Life Res. 2007 Aug;16(6):1053-1063. doi: 10.1007/s11136-007-9209-1.
Matza LS, Johnston JA, Faries DE, Malley KG, Brod M.
Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL).
Qual Life Res. 2007 Nov;16(9):1511-1520. doi: 10.1007/s11136-007-9254-9.
Brod M, Cobden D, Lammert M, Bushnell D, Raskin P.
Examining Correlates of Treatment Satisfaction for Injectable Insulin in Type 2 Diabetes: Lessons Learned From a Clinical Trial Comparing Biphasic and Basal Analogues.
Health Qual Life Outcomes. 2007 Feb;7;5:8. doi: 10.1186/1477-7525-5-8.
Brod M, Skovlund SE, Wittrup-Jensen KU.
Measuring the Impact of Diabetes Through Patient Report of Treatment Satisfaction, Productivity and Symptom Experience.
Qual Life Res. 2006 Apr;15(3):481-491. doi: 10.1007/s11136-005-1624-6.
Brod M, Johnston J, Able S, Swindle R.
Validation of the Adult Attention Deficit Hyperactivity Disorder Quality-of-Life Scale (AAQOL): A Disease-Specific Quality-of-Life Measure.
Qual Life Res. 2006 Feb;15(1):117-129. doi: 10.1007/s11136-005-8325-z.
Brod M, Perwein A, Adler L, Spencer T, Johnston J.
Conceptualization and Assessment of Quality of Life for Adults With Attention Deficit Disorder.
Prim Psychiatry. 2005;12(6):58-64.
Anderson RT, Skovlund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R.
Development and Validation of the Insulin Treatment Satisfaction Questionnaire.
Clin Ther. 2004 Apr;26(4):565-578. doi: 10.1016/s0149-2918(04)90059-8.
Sands LP, Ferreira P, Stewart AL, Brod M, Yaffe K.
What Explains Differences Between Dementia Patients’ and Their Caregivers’ Ratings of Patients’ Quality of Life?
Am J Geriatr Psychiatry. 2004 May-Jun;12(3):272-280.
Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR.
Validation of a General Measure of Treatment Satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), Using a National Panel Study of Chronic Disease.
Health Qual Life Outcomes. 2004 Feb 26;2:12.
Colman SS, Brod M, Potter LP, Buesching DP, Rowland CR.
Cross Sectional 7-year Follow-Up of Anxiety in Primary Care Patients.
Depress Anxiety. 2004;19(2):105-111. doi: 10.1002/da.10140.
Buffum MD, Sands L, Miaskowski C, Brod M, Washburn A.
A Clinical Trial of the Effectiveness of Regularly Scheduled Versus As-Needed Administration of Acetaminophen in the Management of Discomfort in Older Adults With Dementia.
J Am Geriatr Soc. 2004 Jul;52(7):1093-1097. doi: 10.1111/j.1532-5415.2004.52305.x.
Novak A, Brod M, Elbers J.
Andropause and Quality of Life: Findings From Patient Focus Groups and Clinical Experts.
Maturatas. 2002 Dec 10;43(4):231-237. doi: 10.1016/s0378-5122(02)00274-8.
Rothermich EA, Brod MI, Schonfield WH, Rowland CR, Gomez-Mancilla B.
Prospective Study Designs in Outcomes Research: The Case of Migraine.
Pharmacoeconomics. 2002;20(11):715-725. doi: 10.2165/00019053-200220110-00001.
Washburn AM, Luxenberg J, Brod M, Steinhauer M, Katsap M.
A Club of Friends: Enrolling Nursing Home Residents in an Adult Day Program.
J Am Med Dir Assoc. 2001 Sep-Oct;2(5):225-229.
Buffum MD, Miaskowski C, Sands L, Brod M.
A Pilot Study of the Relationship Between Discomfort and Agitation in Patients With Dementia.
Geriatr Nurs. 2001 Mar-Apr;22(2):80-85. doi: 10.1067/mgn.2001.115196.
Colman SS, Brod MI, Krishnamurthy A, Rowland CR, Jirgens KJ, Gomez-Mancilla B.
Treatment Satisfaction, Functional Status, and Health-Related Quality of Life of Migraine Patients Treated With Almotriptan or Sumatriptan.
Clin Ther. 2001 Jan;23(1):127-145. doi: 10.1016/s0149-2918(01)80036-9.
Brod M, Stewart A, Sands L.
Conceptualization of quality of life in dementia.
In: Albert SM, Logsdon RG, eds. Assessing Quality of Life in Alzheimer’s Disease. New York, NY: Springer; c2000.
Brod M, Stewart AL, Sands L, Walton P.
Conceptualization and Measurement of Quality of Life in Dementia: The Dementia Quality of Life Instrument (DQoL).
Gerontologist. 1999 Feb;39(1):25-35. doi: 10.1093/geront/39.1.25.
Whitehouse PJ, Winblad B, Shostak D, Bhattacharjya A, Brod M., et al.
First International Pharmacoeconomic Conference on Alzheimer’s Disease: Report and Summary.
Alzheimer Dis Assoc Disord. 1998 Dec;12(4):266-280. doi: 10.1097/00002093-199812000-00006.
Brod M.
Quality of Life Issues in Patients With Diabetes and Lower Extremity Ulcers: Patients and Care Givers.
Qual Life Res. 1998 May;7(4):365-372. doi: 10.1023/a:1024994232353.
Brod M, Mendelsohn GA, Roberts B.
Patients’ Experiences of Parkinson’s disease.
J Gerontol B Psychol Sci Soc Sci. 1998 Jul;53(4):P213-222. doi: 10.1093/geronb/53b.4.p213.
Buffum MD, Brod M.
Humor and Well-Being in Spouse Caregivers of Patients With Alzheimer’s Disease.
Appl Nurs Res. 1998 Feb:11(1):12-18. doi: 10.1016/s0897-1897(98)80031-1.
Wallhagen MI, Brod M.
Perceived Control and Well-Being in Parkinson’s Disease.
West J Nurs Res. 1997 Feb;19 (1):11-25; discussion 25-31. doi: 10.1177/019394599701900102.
Stewart AL, Brod M.
Measuring health-related Quality of life in older and demented populations.
In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippencott-Raven; 1996.
Weinberg JK, Brod M.
Advance Medical Directives: Policy Perspectives and Practical Experiences.
J Ethics Law Aging. 1995 Spring-Summer;1(1):15-35.
Brod M, Heurtin-Roberts S.
Older Russian Emigrés and Medical Care.
West J Med. 1992 Sep;157(3):333-336.
Farber HJ, Brod M, Feinbloom RI.
Primary Family Contacts and Emotional Health in the Institutionalized Elderly.
Fam Pract Res J. 1991 Sep;11(3):309-317.
Brod M, Feinbloom RI.
Feasibility and Efficacy of Verbal Consents.
Res Aging. 1990 Sep;12(3):364-372. doi: 10.1177/0164027590123005.
Brod M, McHenry E, Plasse TF, Fedorczyk D, Trout JR.
A Randomized Comparison of Poly-Hema and Hydrocolloid Dressings for Treatment of Pressure Sores.
Arch Dermatol. 1990 Jul;126(7):969-970. doi: 10.1001/archderm.126.7.969.
Wolf-Klein GP, Silverstone FA, Levy AP, Brod M.
Screening for Alzheimer's Disease by Clock Drawing.
J Am Geriatr Soc. 1989 Aug;37(8):730-734. doi: 10.1111/j.1532-5415.1989.tb02234.x.
Brown A, Brod M.
Nurse Preferences for Heroic Measures.
Gerontologist. 1988;28:194.
Kirk JC, Brod M.
A Nursing Home Survey of Oral Nutritional Supplementation Formula Use.
Gerontologist. 1988;28:80.
Alvir J, Silverstone F, Brod M, Kelman H.
Risk Factors for Depression.
Gerontologist. 1988;28:331.
Brod M, Chandler B.
Pre- vs. Post- RUGs Differences in Discharge Status of SNF Patients.
Gerontologist. 1988;28(1):125-126.
Wolf-Klein GP, Silverstone FA, Brod M, et al.
Are Alzheimer Patients Healthier?
J Am Geriatr Soc. 1988 Mar;36(3):219-224. doi: 10.1111/j.1532-5415.1988.tb01804.x.
Levy A, Wolf-Klein G, Brod M, Silverstone F.
Clock Drawing Patterns in Alzheimer Patients.
Psychogeriatrics. 1987 Dec;24-25.
Brod M, Wolf-Klein G, Levy A, Silverstone F.
A Rapid Screening Test for Alzheimer’s Disease.
Gerontologist. 1987;27:132.
Foley C, Mitty E, Brod MS.
Why aging makes the skin more vulnerable to breakdown in the presence of wetness due to incontinence and the added effects of pressure.
In: Special Skin Care Problems of the Incontinent Elderly. The Center for Geriatrics, Gerontology and Long Term Care, Columbia University and the New York State Office of Mental Health; 1987.
Feinbloom R, Brod MS.
Changes in the Life Course of the Institutionalized Elderly.
Gerontologist. 1986;26:256.
Feinbloom R, Brod MS.
Researching the Effects of Group Work on the Health of a Long Term Care Population.
Gerontologist. 1985;25:261.
Yazov L, Silverstone FA, Brod M.
Measures of Family Support: Development of a Family Assessment Schedule (FAS) to Assess Caregiver-Ambulatory Elderly Relationships.
Gerontologist. 1985;25:146.
Brod MS, Silverstone FA, Kelman HR.
Evaluation Study: Ambulatory Care of Community Treatment for the Frail Elderly? XIII International Congress of Gerontology, New York, NY, July 1985.
Gerontologist. 1985;25:89.
Brod MS, Hall SM.
Joiners and Non-Joiners in Smoking Treatment: A Comparison of Psychosocial Variables.
Addict Behav. 1984;9(2):217-221. doi: 10.1016/0306-4603(84)90061-3.
Updated: October 15, 2024
